|Articles|April 2, 2021

Pharmaceutical Technology

  • Pharmaceutical Technology-04-02-2021
  • Volume 45
  • Issue 4

Comparing Methods for Determining Out-of-Trend Stability Test Results

This article describes in detail how simulation was used to compare the statistical techniques used to determine out-of-trend (OOT), which is crucial to avoiding out-of-specification (OOS) events for drug substances and products.

Peer-Reviewed

Submitted: Aug. 25, 2020. Accepted: Sept. 8, 2020

Abstract

Trending stability data to identify out-of-trend (OOT) results is a critical part of avoiding out-of-specification (OOS) events for drug substances and products. Analytical OOT is usually caused by an invalid analytical measurement, while process control OOT is typically due to some production- related event. To date, there is still no regulatory guidance on which statistical techniques are best to use for identifying OOT conditions.

Methods such as regression control chart (RegCC), by time tolerance interval (ByTimeTI), slope-by-lot Control Chart (SlopeCC), prediction interval (PI), and Z-score have been described in the literature. However, there had been no systematic evaluation of the effectiveness of each of these methods.

The author has used simulation to compare these methods under varying scenarios of sample size, relative lot-to-lot and within-lot variation, and extent of analytical or process control OOT. Results verified that PI, Z-score, and RegCC were related methods with some slight variation in how each one worked. ByTimeTI was the least effective in detecting either types of OOT. SlopeCC was effective in detecting process control OOT, but, overall, RegCC performed the best at detecting both analytical and process control OOT, although its false alarm rates (Type I error) slightly exceeded 5%. In addition, the method is relatively simple to use, and can be implemented by quality control staffers who have not had in-depth statistical training, or who cannot confer with a statistician.

Click here for PDF of this article.

About the authors

Richard Montes, rmontes@alnylam.com, director of CMC Statistics, Process, and Analytical Sciences at Alnylam Pharmaceuticals, Cambridge, MA, has more than 20 years of experience in the bio/pharmaceutical industry. He received his PhD in Chemical Engineering (ChE) from the Georgia Institute of Technology, his MSChE from Texas Tech University, and his BSChE from St. Louis University.

Article details

Pharmaceutical Technology
Vol. 45, No. 4
April 2021
Pages: 34–43

Citation

When referring to this article, please cite it as R. Montes, “Comparing Methods for Determining Out-of-Trend Stability Test Results,” Pharmaceutical Technology 45 (4) 2021.



Related to this article

PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.